太龙药业: 太龙药业关于超短期融资券获准注册的公告

Core Viewpoint - The company has received approval to register and issue a total of up to 800 million RMB in short-term financing bonds, which will be managed by two banks as joint lead underwriters [1][2]. Group 1 - The company held board meetings on July 1 and July 17, 2025, to approve the application for the issuance of short-term financing bonds [1]. - The registration amount for the short-term financing bonds is set at 800 million RMB, valid for two years from the date of the acceptance notice [1][2]. - The company plans to issue the bonds in phases during the registration validity period, depending on its funding needs and market conditions [2]. Group 2 - The company is required to disclose the issuance results through channels recognized by the trading association after the completion of the bond issuance [2]. - The issuance will comply with relevant laws, regulations, and self-regulatory management rules set by the trading association [2].